[1]. Biological Aging and Survival Outcomes in Patients With Advanced Non-Small Cell Lung Cancer Receiving Systemic Therapy
CLINICAL LUNG CANCER [Volume]27 [Issue]3 [Page]115 -126 （2026/） [Reviewed] Yes
[DOI] [2]. Geriatric nutritional risk index in antifibrotic therapy can predict tolerability and mortality risk.
Scientific reports （2026/） [Reviewed] Yes
[3]. Cold inducible RNA binding protein promotes fibroblast activation and its inhibition represents a potential therapeutic target in pulmonary fibrosis.
Scientific reports [Volume]16 [Issue]1 （2026/） [Reviewed] Yes
[4]. Clinical Characteristics and Prevalence of Apical Scarring at Chest CT in a Healthy Population.
Radiology. Cardiothoracic imaging [Volume]8 [Issue]1 [Page]e250190 （2026/） [Reviewed] Yes
[DOI] [5]. Epidemiology of interstitial lung diseases in Japan: A nationwide database analysis.
Respiratory investigation [Volume]64 [Issue]2 [Page]101367 -101367 （2026/） [Reviewed] No
[DOI]